483 - Use of Terbinafine in Combination with Other Systemic Anti-fungal Agents As Treatment for Invasive Mold Infections. Experience from A National Cancer Institute Designated Cancer Center.

Thursday, October 20, 2022

12:15 PM – 1:30 PM US ET

Location: Virtual

Presenting Author(s)

AS

Anna Sikora, MD

University of South Florida
Tampa, Florida, United States
OK

Olga Klinkova, MD, MSc

Attending
Moffitt Cancer Center
Tampa, Florida, United States
LC

Lisa Cozzini, APRN

Moffitt Cancer Center
Tampa, Florida, United States
YP

Yanina Pasikhova, PharmD

Infectious Diseases/Antimicrobial Stewardship Pharmacist
Moffitt Cancer Center
Tampa, Florida, United States
RQ

Rod Quilitz, PharmD

ID Clinical Pharmacist
Moffitt Cancer Center
Tampa, Florida, United States
Austin R. Morrison, PharmD

Infectious Diseases/Antimicrobial Stewardship Pharmacist
Moffitt Cancer Center
Tampa, Florida, United States
AB

Aliyah Baluch, MD, MSc

Bone Marrow Transplant Infectious Diseases (BMT ID) attending
Moffitt Cancer Center
Tampa, Florida, United States